Study protocol for FASTRAK: a randomised controlled trial evaluating the cost impact and effectiveness of FAST-MRI for HCC suRveillance in pAtients with high risK of liver cancer.
Pierre NahonMaxime RonotOlivier SutterPierre-André NatellaSamia BaloulIsabelle Durand ZaleskiEtienne AudureauPublished in: BMJ open (2024)
Clinical trial number (ClinicaTrials.gov) NCT05095714.